Public Health Journal: Kratom Beverages Rise Unregulated With Marketing Parallels to Opioid Crisis

Why it matters

A peer-reviewed public health journal documents how kratom drink products use marketing strategies similar to those that fueled the opioid crisis—targeting diverse demographics, using appealing flavors and branding, and making unsubstantiated health claims.

The big picture

The kratom market has shifted from traditional leaf to ready-to-drink beverages and concentrated products. These products are widely available and aggressively marketed without FDA oversight. The article highlights regulatory gaps created by DSHEA (Dietary Supplement Health and Education Act) that allow unproven health claims.

Key findings

• Kratom drink products widely available at gas stations, convenience stores, and online; marketing uses wellness language with limited scientific evidence; products contain varying alkaloid concentrations without standardization; regulatory framework relies on dietary supplement category despite opioid-like pharmacology; parallels drawn to early opioid marketing strategies

What they say

Authors Perry and Chin emphasized that 'the unregulated rise of kratom drinks presents emerging challenges requiring policy recommendations including enhanced labeling, standardization of alkaloid content, and consumer education.'

Bottom line

**Kratom beverage marketing mirrors successful opioid expansion strategies, exploiting regulatory gaps and reaching vulnerable populations without FDA oversight.**